Donisi Health is a MedTech company providing in-home health detection solutions for congestive heart failure (CHF) and chronic-disease patients.

SOLUTION

Donisi enables a user-friendly pre-emptive approach to cardiac and pulmonary health monitoring in the home, helping to optimize the continuum of care for patients with CHF and other chronic diseases and avoid unnecessary rehospitalization.

OVERVIEW

Donisi is helping patients with Congestive Heart Failure (CHF) and other chronic cardiopulmonary diseases, freeing them to focus on living their life to the fullest, by monitoring the patient’s health daily to support timely detection of changes in lung fluid content (indicating heart failure exacerbation) and more, thereby avoiding unnecessary rehospitalization. Based on Donisi’s FDA-cleared technology, and backed by 11 granted patents, Donisi’s contact-free health detection works free from wires, wearables, and patches. Our patented AI-based system detects and analyzes multiple health bio-indicators simultaneously, delivering clinically meaningful insights and notifications of changes in key health indicators. Donisi has the only clinically validated contact-free technology that can remotely detect signs of pulmonary congestion and additional parameters key for heart failure exacerbation detection in the home.

2021 ACHIEVEMENTS

- FDA Clearance: Gili Pro BioSensor 

- 11 Granted Patents 

- BIRD Grant Recipient - Partnership with Dell Technologies 

- Winner, MEDinISRAEL 2021, Startup Innovation Competition 

- Winner, Future Unicorn, E&T Innovation 

- Winner, Innovations in Cardiac Intervention (ICI), 2021

Follow on LinkedIn 

Visit Website 

100Plus is the leading AI-assisted remote patient monitoring (RPM)platform. We empower healthcare providers 

to remotely manage chronic conditions, improve patient adherence, reduce hospitalizations & support practices with our end-to-end solution. AI-assisted technology, Esper, improves care coordination & reduces administrative burden.

The leader in connective care solutions to support low-acuity monitoring and aging in place; remote patient monitoring; and chronic condition management.

-

Donisi's Gili Pro BioSensor is the only solution to receive FDA clearance for the simultaneous detection of cardiac and pulmonary health biomarkers through the use of light waves (nano-vibration motion detection).

Not applicable

Artificial Intelligence underpins our integrated RPM platform by increasing patient adherence.